A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors

BackgroundAutophagy is a catabolic process that is triggered in cells during periods of metabolic or hypoxic stress, which enables their survival during this challenge. Autophagy may also impart survival advantage to tumors cells undergoing attack from chemotherapy or radiation. Inhibition of early-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nagla Abdel Karim, Asad Ullah, Imran Ahmad, Elmustapha Bahassi, Olugbenga Olowokure, Ahmed Khaled, Harold Davis, John C. Morris
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-04-01
Col·lecció:Frontiers in Oncology
Matèries:
lung cancer
autophagy
phase 1
solid tumor
chloroquine
Accés en línia:https://www.frontiersin.org/articles/10.3389/fonc.2022.811411/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars